Clinical trial
Phase 1 Exploratory Clinical Study of Microdosing NAP for Optical Molecular Imaging in Human Lungs in Healthy Volunteers and in Patients With Acute Lung Injury in Intensive Care
NCT01532024 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Exploratory Clinical Study of Microdosing NAP for Optical Molecular Imaging in Human Lungs in Healthy Volunteers and in Patients With Acute Lung Injury in Intensive Care
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- September 2, 2016
- Enrollment
- 15 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.